The University of Chicago Header Logo

Connection

Daniel Shevrin to Cisplatin

Back to Details
This is a "connection" page, showing publications Daniel Shevrin has written about Cisplatin.
Daniel Shevrin
Connection Strength
0.086
Cisplatin
  1. Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586). Am J Clin Oncol. 2000 Aug; 23(4):371-5.
    View in: PubMed
    Score: 0.040
  2. Effects of cisplatin on parathyroid hormone- and human lung tumor-induced bone resorption. J Bone Miner Res. 1988 Oct; 3(5):541-6.
    View in: PubMed
    Score: 0.017
  3. Treatment of cancer-associated hypercalcemia with cisplatin. Arch Intern Med. 1987 Feb; 147(2):329-32.
    View in: PubMed
    Score: 0.016
  4. Cis-platinum treatment for malignancy-associated humoral hypercalcemia in an athymic mouse model. Calcif Tissue Int. 1984 Sep; 36(5):559-62.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.